Two companies have combined efforts to develop a urine-based test for three sexually transmitted diseases.
Calypte Biomedical Corporation and Becton, Dickinson and Company will promote the Sentinel Testing Service for HIV, chlamydia, and gonorrehea. This could revolutionize testing because the urine-based system eliminates the much feared needle testing and uncomfortable urogenital swab collection methods.
More importantly, this further eliminates risk for healthcare workers becoming potentially infected by HIV positive blood.
Studies have shown that many Americans shy away from STD tests that require a blood sample or a urogenital swab. However, urine samples offer an inexpensive and simple method of collection.
Officials creating the new test hope this simplicity will carry over to smaller community outreach programs and epidemiologic studies. Individuals without medical training will be able to administer the test.
Licensed medical professionals can order the test on the Sentinel website or by phone.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.